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Ten of 143 systemic lupus erythematosus patients dem-
onstrated urticaria-like lesions. Lesional biopsies in 7 of 
9 patients tested revealed a leukocytoclastic angiitis and 
in 2, a mononuclear perivascular infiltrate. Direct im-
munofluorescent studies in 2 of6 patients tested revealed 
IgM and C3 deposition in and about dermal blood vessels. 
Nine of the 10 systemic lupus erythematosus patients 
displayed active clinical disease (e.g., arthritis, renal 
disease, etc.), a positive lupus band test, antibodies 
against deoxyribonucleic acid or Sm macromolecules, 
serum hypocomplementemia and markedly elevated 
quantities of serum immune complexes as determined 
by an immunoradiometric assay employing Raji cells. 
Similar lesions were not detected in 35 discoid lupus 
erythematosus patients. 
These studies strongly suggest: (1) urticaria-like le-
sions are uncommon cutaneous manifestations of sys-
temic lupus erythematosus. (2) These urticaria-like le-
sions do not represent a classic IgE mediated urticaria. 
(3) These urticaria-like lesions generally occur in lupus 
erythematosus patients demonstrating clinical and/or 
serological evidence of systemic disease activity. (4) 
These lesions are probably secondary to immune com-
plex deposition. 
We, therefore, conclude that all urticarial lesions in 
lupus erythematosus patients should be biopsied and the 
patient evaluated for active systemic disease. 
Classic urticaria is characterized as an erythematosus, edem-
atous, sharply dema1·cated, frequently pruritic lesion generally 
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Abbreviations: 
LBT: Lupus Band Test-Uninvolved extensor surface of proximal 
1/3 of foreru·m employed· as the biopsy site. 
n-DNA: Native Deoxyribonucleic acid (double stranded DNA) . 
ss-DNA: Single stranded Deoxyribonucleic acid (single-stranded 
DNA). 
*SM: A non-nucleic acid nuclear macromolecule. 
n-RNP: Nuclear ribonucleic acid protein. 
*Ro(SSA): Cytoplasmic non-nucleic acid macromolecule. Identical 
with A antigen described in Sjogren's Syndrome (SSA) [1]. 
*La(SSB): A cytoplasmic and nuclear macromolecule. Identical to 
the B antigen in Sjogren's Syndrome (SSB) [1]. 
CH50: Term employed to designate total serum hemolytic com-
plement. 
Raji cell: Lymphoblastoid B cell with avid complement cell surface 
receptors and weak receptors for the Fe portion of IgG. 
"' Abbreviation of patients surname in whose serum the antibody 
system was originally detected. 
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lasting 4-6 hr. Histologically these lesions demonstrate dermal 
edema with little or no cellular infil trate. These lesions are 
thought to represent the cutaneous manifestation of an lgE 
mediated immune response. Urticaria is recognized as a cuta-
neous manifestation of systemic lupus erythematosus (SLE) 
occurring with varying degrees of freq uency (2-5]. 
Recently, urticaria has also been recognized as a cutaneous 
manifestation of a necrotizing vasculitis [6- 7]. This urticaria-
like vasculitic lesion, in contradistinction to t rue wt icaria, gen-
erally persists for prolonged periods of time (i.e., >24 hr) . 
Histologically these lesions demonstrate a leukocytoclastic an-
giitis and are thought to represent th e cutaneous manifestation 
of immune complex blood vessel wall deposition. Most patients 
reported with urticaria-like vasculit is have a chronic disease 
characterized predominantly by serum hypocomplementemia. 
Systemic disease characterized by artlu·itis and glomerulone-
phritis has been noted with varying degrees of frequency in 
these patients (6-13]. It recently has been recognized that these 
patients frequently develop a rapidly progressive obstructive 
lung disease (McDuffie F, personal conununication, July, 1979 
and Provost TT, unpublished observations). In th e vast major-
ity of these wticaria-like vasculitic patients, no serologic evi-
dence of lupus erythematosus has been detected. R ecently, 
however, O'Loughlin, Schroeter, and Jordon [14) have de-
scribed the occurrence of urticaria-like vasculit ic lesions in SLE 
patients. 
Reported in this article, is the evaluation of 10 SLE patients 
who demonstrated prominent urticaria-like lesions. These 10 
patients were detected over an 8 yr period of time. 
MATERIALS AND METHODS 
One hundred and forty-three patients satisfying the American Rhe~­
matological Association's (ARA) criteria for the diagnosis of SLE [15] 
and 35 discoid lupus erythema tosus (DLE) patients (defined as the 
presence of coined shaped lesions in the absence of clinical signs and 
symptoms of systemic disease and the absence of serological evidence 
of nucleru· and cytoplasmic antibodies) have been evaluated. These 
patients have been followed in a lupus clinic or seen in consultation by 
one or more of the authors. 
Antinuclear antibodies were detected employing standard immuno-
fluorescent techniques and mouse Liver as a substrate. Antinative 
deoxyribonucleic acid (nDNA) antibodies were detected utilizing Crith-
idea luciliae as a substrate and a fluorescein conjugated rabbit anti-
human IgG antisera [16]. Anti Sm, nucleaJ· ribonuclear protein (nRNP), 
Ro (SSA) and La (SSB) antibodies were detected employing gel double 
diffusion techniques, calf thymic and human spleen extracts and ref-
erence sera as previously described [1 , 17-19]. 
Single stranded deoxyribonucleic acid (ssDNA) was measured em-
ploying a microcomplement fixa tion assay as previously described 
[20]. 
Skin biopsies of lesions were examined for evidence of vasculitis 
employing hematoxylin arid eosin stains. Six lesional biopsies were 
processed for direct immunofluorescent staining employing fluorescein 
conjugated rabbit anti human IgG, lgM, lgA, IgE and C3 antisera as 
previously described [21]. 
The lupus band test (LBT) was performed employing biopsies taken 
from nonlesional skin of the upper 1/ 3 of the extensor forearm as 
previously described [22]. 
Serum hemolytic complement expressed as a CH50 was determined 
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by the routine laboratory employing a modification of the technique by 
Mayer and Kabat [23]. 
Sera for immune complex quantitation were collected at room tem-
perature, clotted for 1 hr, aliquoted and frozen at -40° or -70°C until 
tested. Immune complex determination was performed employing Raji 
cells and a 1'25 labeled rabbit anti human IgG antisera. The quantity of 
serum immune complexes were expressed as 11g equivalents of aggre-
gated human lgG. 
The Raji cells, a B cell lymphoblastoid cell line, are derived from a 
patient with Burkitt's lymphoma [24 , 25]. These cells contain surface 
receptors for the Fe portion of IgG, C3b, C3d and other complement 
components. These cells were cultured in RPMI-1640 (Gibco) supple-
mented with 1% heat inactivated fetal calf serum (Microbiological 
Associates) and 1% penicillin-streptomycin (Gibco) in 75mm2 T flasks 
(Corning). Cultures seeded with 2 X 105 cells/cc were harvested after 
72 hr in culture and used for the assay. All cultures exceeded 85% 
viability as determined by trypan blue dye exclusion. 
Rabbit anti human IgG (Fe) antisera were purchased commercially 
(Cappel) and demonstrated to be monospecific by gel double diffusion 
and immunoelectrophoresis. This antisera was iodinated with 1' 2'' (New 
England Nuclear) employing the chloramine T technique [26]. 
Aggregated human lgG was prepared from Cohn fraction II by anion 
exchange chromatography (DEAE-52) and freed from aggregates by 
centrifugation at 150,000g for 90 min. The upper 1/3 of the supernatant 
(78 IgG) was removed and the protein concentration determined [27]. 
Aggregates of IgG were then prepared by heating the supernatant at 
63 ° for 30 min. This aggregated lgG was then incubated at 37°C for 30 
min with fresh human serum. These prepared complexes were em-
ployed as positive controls and to construct a standard curve to quan-
titate the complexes. 
The 72 hr Raji cell cultures were washed in 30 cc of RPMI-1640 to 
remove C3 receptor activity in the supernatant. 2 x 106 Raji cells in 25 
~ of RPMI-1640 were reacted with 25 111 of a 1:4 dilution of the serum 
to be tested in 1.5 ml centrifuge tubes (Eppendorf) incubated in a 
shaker bath to maintain suspension at 37°C for 45 min. The cells were 
then washed x 3 with RPMI-1640 and then reacted with an optimum 
amount ofl125 anti-human lgG in RPM! containing 0.5% human serum 
albumin (RPMI-1640 HSA). The cells were then incubated at 4°C for 
30 min in a shaker bath. The cells were then subsequently washed X 3 
with RPMI-1640 HSA and then the peLlet was counted in a gamma 
counter. 
RESULTS 
All lupus patients demonstrating urticaria-like lesions were 
ANA positive (titer >30) and satisfled the ARA criteria for the 
diagnosis of SLE. No patients with benign cutaneous lupus 
(discoid) demonstrated similar lesions. 
Brief clinical summaries of these 10 patients are presented in 
Table I. It can be noted that in 2 patients (patient 1 and 2), the 
urticaria-like lesions were prominent cutaneous features at the 
Vol. 75, No. 6 
time the diagnosis of systemic lupus erythematosus was estab-
lished. In the other 8 patients, the urticaria-like lesions occurred 
as the steroid dosage was being gradually tapered or stopped 
(patient 6). In all but one patient (patient 5), the occunence of 
these lesions was associated with deflnite clinical signs of active 
disease (e.g., arthralgias, arthritis, renal disease, etc.). Patient 
5 had severe psychiatric disease, which made assessment of 
clinical disease activity difficult. 
The laboratory studies in these 10 patients are presented in 
Table II. All but one patient (patient 8) demonstrated a positive 
lupus band test and serum hypocomplementemia. Eight of 
these 10 patients demonstrated clinical renal disease and 6 of 
these 8 patients had renal biopsy confirmation of the renal 
disease. Nine of these 10 patients had anti DNA and/or Sm 
antibodies. Patient 5's serum contained an unidentilled precip-
itin antibody system against calf thymic extract. 
Nine of these 10 patients demonstrated markedly elevated 
levels of serum immune complexes by an immunoradioassay 
utilizing Raji cells (Fig 1). The qu~ntity of serum immune 
complexes in the SLE patients with urticaria-like lesions were 
compared with 10 normal healthy individuals and 24 steroid 
treated patients without evidence of cutaneous vasculitis. The 
24 SLE patients were chosen at random from our lupus clinic 
population. The quantity of serum immune complexes in all 
but one of the urticaria-like patients was above the mean level 
of serum immune complexes detected in the randomly selected 
general lupus population. 
Routine histopathology of the urticaria-like lesions demon-
strated 2 types of histologic lesions. In 7 patients a necrotizing 
vasculitis was seen (Fig 2). In 2 patients, biopsies demonstrated 
a perivascular mononuclear inftltrate. One of the latter 2 pa-
tients (patient 8) had 4 biopsies performed designed to examine 
the histology of the earliest urticaria-like lesion. Repeated 
sections of these biopsies revealed only a perivascular mono-
nuclear inftltrate. No necrotizing (leukocytoclastic) angiitis, 
could be detected. A single biopsy performed on an "iris" lesion 
(patient 10) revealed a perivascular mononuclear infiltrate. 
Two of 4 urticaria-like lesion patients, demonstrating a nec-
rotizing vasculitis, displayed upon direct immunofluorescent 
examination, the deposition of IgM and C3 deposition in their 
diseased blood vessel walls (Fig 3). No blood vessel wall Ig and/ 
or C' deposition was detected in the lesional biopsies of the 2 
patients who demonstrated a perivascular mononuclear infil-
trate. No blood vessel wall deposition was noted in the biopsies 
performed on normal appearing skin of the upper 1/3 of the 
extensor forearm (the lupus band test). 
TABLE I. Clinical data 
Case No. 
2 
3 
4 
5 
6 
7 
8 
9 
10 
Clinical data 
On no therapy; fever, arthritis and erythematous, edematous, urticaria-like lesions persisting for several days over the 
entire body, including the palms; 3+ proteinuria. 
On no therapy; 7 month history of ruthralgias and fatigue. Two weeks prior to admission developed persistent urticaria-
like lesions over entire body, including the palms; 2+ proteinuria. 
Known SLE patient with arthritis and flexion contractures; poorly controLled on aspirin and 10 mg of prednisone. Several 
discrete urticru·ia-like lesions present on neck and upper arms for several weeks; 1+ proteinuria. 
Known SLE patient with membrana-proliferative glomerulonephritis on 20 mgm of prednisone; developed urticaria-Like 
lesions over the arms and trunk; .l esions persisted for days; 4+ proteinuria (nephrotic syndrome) . 
Known SLE patient with major psychiatric problems and a disease process characterized by arthritis; on 10 mg of 
prednisone; 1 mo prior to admission developed urticaria-like lesions over arms and lower extremities. These individual 
Lesions persisted and the u.rticru·ia-like lesions on the legs developed petechiae. 
Known SLE patient with severe a lcoholism; stopped all medications; developed fever, arthra..lgias and urticaria-like lesions 
over ru·ms and hands, including the palms. These individual lesions persisted for days; 2+ proteinuria. 
Known SLE patient with personality disorder and arthritis; on 25 mg of prednisone. Developed fever, wticru·ia-Like lesions 
and pl'Oteinuria. 
Arthralgias, malaise, fatigue and swelling of face were major features of this patient's disease. Treated successfuLly with 
20 mg of Prednisone. Upon discontinuation of therapy, developed classic discoid lesions and urticaria-like lesions of 
arms, legs, palms and soles similar, if not identical in distribution and morphology, to erythema multiforme. 
Known SLE patient with tapering of the prednisone, developed an exacerbation of her disease process chru·acterized by 
urticaria-l ike les ions over trunk and legs, arthritis and proteinuria. 
SLE patient with central nervous system symptoms, developed arthritis, proteinuria and large urticaria-like lesions, some 
of which included typical "iris" lesions of erythema multiforme. 
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TABLE II. Laboratory data urticaria-1iJ~e lesions 
Case No. Lupus Renal band test pathology 
IgM Focal proliferative glomer-
ulonephxitis 
2 lgG Membranous glomerulo-
lgM neplu·itis 
3 IgG Focal proliferative glomer-
lgM ulonephritis 
C3 
4 IgM Focal proliferative glomer-
lgG ulonephritis 
lgE 
C3 
5 lgG None 
C3 
6 lgA Diffuse proliferative glo-
lgG meruloneplu·itis 
7 lgG Focal proliferative glomer-
IgM ulonephritis 
8 Neg None 
9 IgG Proteinuria 
IgM 
10 IgG Proteinuria 
a ssDNA antibodies only; no nDNA antibodies detected. 
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FIG 1. Demonstrates the results of an 1125 rabbit anti-human IgG 
immunoractiometric assay employing Raji ce lls to measure immune 
complexes. The amount of immune complexes is expressed as 11-g 
equivalents of aggregated lgG. The mean concentration of immune 
complexes in SLE patients with w·ticaria-like lesions was 900 Jl.g/ml 
compared to the mean quantity of immune complexes in a steroid 
treated general lupus population without urticaria-like lesion of 260 11-g/ 
ml (P < 0.01). The concentration of immune complexes in the general 
lupus population (260 11-g/ml) compared to normal controls (30 11-g/ ml) 
is also significant (P < 0.01). 
DISCUSSION 
In 9 of 10 lupus patients, wticaria-like lesions occurred in the 
presence of clinically active systemic disease. These SLE pa-
tients also demonstrated serologic evidence of disease activity 
and all demonstrated elevated serum immune complexes com-
pared to normal controls. Similar lesions were not detected in 
patients with benign cutaneous (discoid) lupus or in systemic 
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FIG 2. Sn1all dermal papillary blood vessel involvement with an 
inflammatory process characterized by fibrinoid necrosis and a poly-
morphonuclear infiltration. Leukocytoclysis is evident (hematoxylin 
and eosin, X 400). 
lupus patients controlled with steroids and/or immunosuppres-
sive agents. Thus, we conclude these urticaria-like lesions are 
generally found in lupus patients with active systemic disease 
and are, therefore, a cutaneous sign strongly suggesting t he 
diagnosis of systemic and not benign cutaneous (discoid) lupus. 
O'Loughlin, Sclu-oeter, and Jordon [14) presented data on 9 
SLE patients with urticaria-like lesions which histologically 
demonstrated a leukocytoclastic angiitis. Two additional pa-
tients with urticaria-like lesions failed to display a necrotizing 
vasculitis. One demonstrated a pedvascular lymphohistiocytic 
infiltrate, the other, a perivascular leukocytic infiltrate. OuT 
studies confrrm and extend these initial observations. Om stud-
ies have demonstrated that all of our patients possessed clinical 
and/or serologic evidence of active disease. Our data, howeve1·, 
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FIG 3. Biopsy of urticaria-like lesion demonstrating IgM granular 
deposition at the dermal epidermal junction and in and about dermal 
papillary blood vessels (X 400). 
FIG 4. Demonstrates a characteristic urticaria-like vasculitic lesion 
in patient #6. These lesions are easily classified as erythema inultiforme 
for they persist for greater than 24 hr. 
are somewhat different from the experience reported by 
O'Loughlin, Sohroeter, and Jordon. These investigators indi-
cated that urticaria is a relatively common event in SLE. They 
demonstrated a 22% prevelance (12 of 54 patients). It must be 
noted that these investigators were working in a nationally and 
internationally noted midwestern referral center and were un-
doubtedly dealing with a highly selected referral patient popu-
lation. We think this resulted in these investigators seeing and 
evaluating a high proportion of difficult SLE patients with 
active disease. On the contrary, our patient population was 
drawn predominantly from a neighborhood population served 
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by the hospitals. Our study demonstrates a 7% prevelance of 
urticaria-like lesions in SLE. We feel this is more reflective of 
the true prevalence of this cutaneous manifestation of SLE and 
is similar to the data reported in the large series by Harvey et 
al [2] and Tuffanelli and Dubois [5]. 
Classification of these urticaria-like lesions proved to be 
difficult. Clinically these lesions differed from classic urticaria 
by their persistence. Some of the individual lesions persisted 
for as long as one week. (Classic urticaria, on the contrary, is 
usually a transient disease generally lasting 4-6 hr.) In addition, 
many of our patients with urticaria-like vasculitis complained 
of burning pruritis and noted an annoying hyperesthesia follow-
ing the application of light pressure to the individual lesions. 
These urticaria-like lesions were also unusual because of their 
pattern of distribution. In 4 of these patients, prominent urti-
caria lesions were detected on the palmar swfaces (patients 1, 
2, 6, 8). This distribution pattern plus the persistence of the 
urticaria-like lesions prompted several referring dermatologists 
to seriously question the diagnosis of erythema multiforme. 
Indeed one of the patients (patient 10) had a typical "iris" 
lesion in the inner aspect of the left thigh. No bulla or mucous 
membrane lesions, however, were noted in any ofthese patients. 
In summary these urticaria-like lesions occupied a clinical 
spectrum extending from urticaria to lesions highly suspicious 
of erythema multiforme. 
These lesions also posed a problem histologically. None of 
the lesions demonstrated the features of classic lgE mediated 
urticaria, i.e., dermal edema, in the absence of inflammatory 
cells. All our patients displayed a cellular infiltrate. In 7 pa-
tients, a necrotizing vasculitis was detecte~. In 2, a perivascular 
mononuclear infiltrate was noted. Clinically, one could not 
differentiate the urticaria-like lesions associated with the peri-
vascular mononuclear infiltrate from those urticaria-like lesions 
associated with a necrotizing vasculitis. 
The lowest quantity of serum immune complexes (182 p.g 
equivalents of aggregated lgG) occurred in one of the patients 
demonstrating a mononuclear infiltrate (patient 10). The other 
patient with a perivascular mononuclear infiltrate (patient 8) 
had an immune complex level of 400 p.g equivalents of aggre-
gated IgG. 
No difference between patients with these 2 histologic types 
of urticaria-like lesions could be detected in the other serologic 
tests performed. 
It must be emphasized that these urticaria-like lesions in all 
probability do not represent a Type I (lgE mediated) event. 
The leukocytoclastic angiitis noted in 7 patients is similar to a 
Type III (immune complex) mediated reaction. Indeed, the 
data presented above, are consistent with the hypothesis that 
the majority of the urticaria-like lesions (those demonstrating 
a necrotizing angiitis) are cutaneous manifestations of the sys-
temic immune complex disease. 
The mononuclear perivascular infiltrate in 2 of these patients 
is more difficult to explain. It is conceivable that this type of 
inflammatory infiltrate represents a late evolution of the more 
classic arthus phenomena and this would also explain the 
absence of lg and C' blood vessel deposition which are noted 
frequently in biopsies of early but not late vasculitic lesions. 
Recent studies in erythema multiforme (EM) suggest that at 
least some EM lesions in which a mononuclear perivascular 
infiltrate was noted may be the cutaneous manifestation of an 
immune complex mediated disease. Some early EM lesions do 
demonstrate IgMand C3 deposition in diseased blood vessels 
[28]. Furthermore, bullae. of some EM patients demonstrate 
hypocomplementemia and immune complexes [29]. In addition, 
very recent data indicates that these EM patients frequently 
demonstrate serum immune complexes as determined by the 
Clq and Raji cell techniques [30-32]. 
The observations presented in this study indicate that urti-
caria-like lesions occur infrequently in lupus patients. Some of 
these urticaria lesions are indistinguishable from the urticaria-
like lesions seen in EM. These urticaria lesions are generally 
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fou n d in lupus patients with clinical and serological evidence of 
an active SLE process. These lesions do not represent the 
classic urticaria lesion mediated by an IgE immune response. 
On t h e other hand, not all these urticaria lesions histologically 
demonstrate a necrotizing angiit is. Whether the mononuclear 
perivascular inflammatory infil trate seen in the minority of our 
urti caria SLE patients represent the late evolutionary stage of 
a leukocytoclastic angii tis or a poorly defmed immune complex 
m e diated mononuclear response or a non immune complex 
m e diated inflammatory mechanism remains for fu ture research 
to define. 
NOTE A DDED SINCE SUBMISSION 
Anderson and Stillman, J Clin Invest 66:353-360, 1980 have recently 
pu blished data indicating that the Raji ce ll immunoradioassay detects 
both immune complexes and anti-lymphocyte antibodies in SLE sera. 
T h e Raji cell data reported in this report, thus, cannot be assumed to 
represent only the presence of immune complexes. 
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